Taysha Gene Therapies Inc (NAS:TSHA)
$ 5.02 -0.14 (-2.71%) Market Cap: 1.64 Bil Enterprise Value: 1.24 Bil PE Ratio: 0 PB Ratio: 4.22 GF Score: 33/100

Taysha Gene Therapies Inc at Guggenheim Genomic Medicines and Rare Disease Day (Virtual) Transcript

Apr 1, 2022 / 08:00 PM GMT
Release Date Price: $6.34 (-2.76%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TSHA.OQ - Taysha Gene Therapies Inc
Taysha Gene Therapies Inc at Guggenheim Genomic Medicines and Rare Disease Day (Virtual)
Apr 01, 2022 / 08:00PM GMT

=====================
Conference Call Participants
=====================
* Debjit Chattopadhyay
Guggenheim Securities - Senior Biotech Analyst
* Suyash Prasad
Taysha Gene Therapies Inc. - Chief Medical Officer
* Kamran Alam
Taysha Gene Therapies Inc. - CFO

=====================
Presentation
--------------------------------------------------------------------------------
Debjit Chattopadhyay, Guggenheim Securities - Senior Biotech Analyst [1]
--------------------------------------------------------------------------------
Good afternoon and thank you for joining Guggenheim's genomic medicines and rare disease conference day 2 and the last fireside chat of the event. I am Debjit, and one of the analysts representing Guggenheim Therapeutics team. Our privilege to host Taysha's Chief Medical Officer and head of R&D Suyash
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot